Controls minus patients | Acute minus remission phase (cases) | ||||
---|---|---|---|---|---|
Acute phase | Remission phase | ||||
MDA (nmol/ml) | −0.14 (−0.33 to 0.05) p = 0.15 | −0.18 (−0.34 to −0.02) p = 0.035 | −0.04 (−0.26 to +0.18) p = 0.73 | ||
GSH (mg/100 ml) | 4.25 (−1.0 to 9.5) p = 0.12 | 0.8 (−5.45 to 7.05) p = 0.79 | −3.45 (−10.23 to +3.33) p = 0.32 | ||
Vitamin E (μg/100 ml) | 69 (46.32 to 91.68) p < 0.001 | 46.55 (20.13 to 72.97) p = 0.002 | −22.45 (−4.05 to –40.85) p = 0.02 | ||
Cholesterol (mg/100 ml) | −8.9 (−3.94 to −13.86) p = 0.002 | −7.0 (−2.09 to −11.91) p = 0.008 | +1.9 (−3.46 to +7.26) p = 0.50 | ||
G6PD (mU/ml) | 58.45 (119.93 to 196.97) p < 0.001 | 133.05 (94 to 172.1) p < 0.001 | −25.85 (−64.69 to +12.99) p = 0.20 |
G6PD, glucose-6-phosphate dehydrogenase; GSH, reduced glutathione; MDA, malonyldialdehyde.